These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

371 related items for PubMed ID: 8958218

  • 1. Relative potency of testosterone and dihydrotestosterone in preventing atrophy and apoptosis in the prostate of the castrated rat.
    Wright AS, Thomas LN, Douglas RC, Lazier CB, Rittmaster RS.
    J Clin Invest; 1996 Dec 01; 98(11):2558-63. PubMed ID: 8958218
    [Abstract] [Full Text] [Related]

  • 2. Androgen-induced regrowth in the castrated rat ventral prostate: role of 5alpha-reductase.
    Wright AS, Douglas RC, Thomas LN, Lazier CB, Rittmaster RS.
    Endocrinology; 1999 Oct 01; 140(10):4509-15. PubMed ID: 10499505
    [Abstract] [Full Text] [Related]

  • 3. [Effect of selective 5alpha-reductase inhibitor or/and testosterone undecanoate on the reproductive function of male rats].
    Jia Y, Cue YG, Wang XD, Wang XH, Tong JS, Ma DZ, Cai RF, Di FS.
    Zhonghua Nan Ke Xue; 2005 Jan 01; 11(1):38-41. PubMed ID: 15704680
    [Abstract] [Full Text] [Related]

  • 4. Influence of diethylstilbestrol, Leuprolelin (a luteinizing hormone-releasing hormone analog), Finasteride (a 5 alpha-reductase inhibitor), and castration on the lobar subdivisions of the rat prostate.
    Yamashita A, Hayashi N, Sugimura Y, Cunha GR, Kawamura J.
    Prostate; 1996 Jul 01; 29(1):1-14. PubMed ID: 8685049
    [Abstract] [Full Text] [Related]

  • 5. The antigonadotropic action of testosterone but not 7alpha-methyl-19-nortestosterone is attenuated through the 5alpha-reductase pathway in the castrated male rat pituitary gland.
    Bandivdekar AH, Karp R, Sundaram K, Kumar N.
    J Androl; 2000 Jul 01; 21(2):268-75. PubMed ID: 10714822
    [Abstract] [Full Text] [Related]

  • 6. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW.
    Endocrinology; 1997 Mar 01; 138(3):871-7. PubMed ID: 9048585
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of 5alpha-reductase in rat prostate reveals differential regulation of androgen-response gene expression by testosterone and dihydrotestosterone.
    Dadras SS, Cai X, Abasolo I, Wang Z.
    Gene Expr; 2001 Mar 01; 9(4-5):183-94. PubMed ID: 11444528
    [Abstract] [Full Text] [Related]

  • 8. The role of transforming growth factor-beta1, -beta2, and -beta3 in androgen-responsive growth of NRP-152 rat prostatic epithelial cells.
    Lucia MS, Sporn MB, Roberts AB, Stewart LV, Danielpour D.
    J Cell Physiol; 1998 May 01; 175(2):184-92. PubMed ID: 9525477
    [Abstract] [Full Text] [Related]

  • 9. Androgen sensitivity of prostate epithelium is enhanced by postnatal androgen receptor inactivation.
    Simanainen U, McNamara K, Gao YR, Handelsman DJ.
    Am J Physiol Endocrinol Metab; 2009 Jun 01; 296(6):E1335-43. PubMed ID: 19366880
    [Abstract] [Full Text] [Related]

  • 10. Dutasteride, the dual 5alpha-reductase inhibitor, inhibits androgen action and promotes cell death in the LNCaP prostate cancer cell line.
    Lazier CB, Thomas LN, Douglas RC, Vessey JP, Rittmaster RS.
    Prostate; 2004 Feb 01; 58(2):130-44. PubMed ID: 14716738
    [Abstract] [Full Text] [Related]

  • 11. Pharmacologic basis for the enhanced efficacy of dutasteride against prostatic cancers.
    Xu Y, Dalrymple SL, Becker RE, Denmeade SR, Isaacs JT.
    Clin Cancer Res; 2006 Jul 01; 12(13):4072-9. PubMed ID: 16818707
    [Abstract] [Full Text] [Related]

  • 12. Combined effect of the finasteride and doxazosin on rat ventral prostate morphology and physiology.
    Justulin LA, Acquaro C, Carvalho RF, Silva MD, Felisbino SL.
    Int J Androl; 2010 Jun 01; 33(3):489-99. PubMed ID: 19490185
    [Abstract] [Full Text] [Related]

  • 13. Evidence for atrophy and apoptosis in the ventral prostate of rats given the 5 alpha-reductase inhibitor finasteride.
    Rittmaster RS, Manning AP, Wright AS, Thomas LN, Whitefield S, Norman RW, Lazier CB, Rowden G.
    Endocrinology; 1995 Feb 01; 136(2):741-8. PubMed ID: 7835306
    [Abstract] [Full Text] [Related]

  • 14. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
    Lamb JC, English H, Levandoski PL, Rhodes GR, Johnson RK, Isaacs JT.
    Endocrinology; 1992 Feb 01; 130(2):685-94. PubMed ID: 1733716
    [Abstract] [Full Text] [Related]

  • 15. [Epididymis in an experimental model of DHT deficiency: immunolocalization of ERalpha and ERbeta in rat epididymal epithelial cells. In vivo and in vitro studies].
    Kolasa A.
    Ann Acad Med Stetin; 2006 Feb 01; 52(2):13-21; discussion 21. PubMed ID: 17633123
    [Abstract] [Full Text] [Related]

  • 16. Estradiol and high-dose dihydrotestosterone treatment causes changes in cynomolgus monkey prostate volume and histology identical to those caused by testosterone alone.
    Kamischke A, Weinbauer GF, Semjonow A, Lerchl A, Richter KD, Nieschlag E.
    J Androl; 1999 Feb 01; 20(5):601-10. PubMed ID: 10520572
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of 5alpha-reductase blocks prostate effects of testosterone without blocking anabolic effects.
    Borst SE, Lee JH, Conover CF.
    Am J Physiol Endocrinol Metab; 2005 Jan 01; 288(1):E222-7. PubMed ID: 15367394
    [Abstract] [Full Text] [Related]

  • 18. Morphological and hormonal changes in the ventral and dorsolateral prostatic lobes of rats treated with finasteride, a 5-alpha reductase inhibitor.
    Prahalada S, Rhodes L, Grossman SJ, Heggan D, Keenan KP, Cukierski MA, Hoe CM, Berman C, van Zwieten MJ.
    Prostate; 1998 May 15; 35(3):157-64. PubMed ID: 9582084
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of MENT on primary cell cultures from benign prostatic hyperplasia and prostate carcinoma.
    Mendoza P, Sánchez C, Contreras HR, Vergara J, Acevedo C, Cabezas J, Huidobro C, Noé G, Castellón EA.
    Int J Androl; 2009 Dec 15; 32(6):607-15. PubMed ID: 18637152
    [Abstract] [Full Text] [Related]

  • 20. Androgen and prostatic stroma.
    Niu YJ, Ma TX, Zhang J, Xu Y, Han RF, Sun G.
    Asian J Androl; 2003 Mar 15; 5(1):19-26. PubMed ID: 12646998
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.